Abstract
OBJECTIVE--To compare the efficacy and safety of terbinafine 1% cream and clotrimazole 1% cream in the treatment of tinea pedis. DESIGN--Multicentre, double blind parallel group study. SETTING--32 general practices and one hospital. PATIENTS--256 patients with mycologically confirmed tinea pedis. Of the 211 patients evaluable, 107 were randomised to terbinafine (75 male, 32 female; mean (range) age 40 (12-81) years) and 104 to clotrimazole (79 male, 25 female; mean (range) age 36 (12-71) years). INTERVENTIONS--Terbinafine 1% cream applied twice daily for one week and inert cream applied twice daily for the next three weeks. Clotrimazole 1% cream applied twice daily for four weeks. MAIN OUTCOME MEASURES--Mycological cure (negative results on microscopy and culture) and effective treatment (mycological cure plus no or minimal signs and symptoms) measured at weeks 1, 2, 3, 4, and 6. RESULTS--At week four rates of mycological cure were 93.5% for terbinafine and 73.1% for clotrimazole (p = 0.0001); and at week six 97.2% for terbinafine and 83.7% for clotrimazole (p = 0.001). Rates of effective treatment at week 4 were 89.7% for terbinafine and 58.7% for clotrimazole (p = 0.0001); and 89.7% for terbinafine and 73.1% for clotrimazole (p = 0.002) at week 6. CONCLUSION--These results indicate that a one week course of terbinafine 1% cream is more effective in the treatment of tinea pedis than a four week course of clotrimazole 1% cream, both in terms of mycological cure and effective treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berman B., Ellis C., Leyden J., Lowe N., Savin R., Shupack J., Stiller M., Tschen E., Zaias N., Birnbaum J. E. Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials. J Am Acad Dermatol. 1992 Jun;26(6):956–960. doi: 10.1016/0190-9622(92)70141-2. [DOI] [PubMed] [Google Scholar]
- Clayton Y. M. In vitro activity of terbinafine. Clin Exp Dermatol. 1989 Mar;14(2):101–103. doi: 10.1111/j.1365-2230.1989.tb00901.x. [DOI] [PubMed] [Google Scholar]
- Greer D. L., Jolly H. W., Jr Treatment of tinea cruris with topical terbinafine. J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):800–804. doi: 10.1016/0190-9622(90)70292-p. [DOI] [PubMed] [Google Scholar]
- Griffiths C. E., Fisher G. J., Finkel L. J., Voorhees J. J. Mechanisms of action of retinoic acid in skin repair. Br J Dermatol. 1992 Sep;127 (Suppl 41):21–24. doi: 10.1111/j.1365-2133.1992.tb16983.x. [DOI] [PubMed] [Google Scholar]
- Hill S., Thomas R., Smith S. G., Finlay A. Y. An investigation of the pharmacokinetics of topical terbinafine (Lamisil) 1% cream. Br J Dermatol. 1992 Oct;127(4):396–400. doi: 10.1111/j.1365-2133.1992.tb00461.x. [DOI] [PubMed] [Google Scholar]
- Millikan L. E. Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris. J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):795–799. doi: 10.1016/0190-9622(90)70291-o. [DOI] [PubMed] [Google Scholar]
- Petranyi G., Meingassner J. G., Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother. 1987 Sep;31(9):1365–1368. doi: 10.1128/aac.31.9.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sud I. J., Feingold D. S. Mechanisms of action of the antimycotic imidazoles. J Invest Dermatol. 1981 Jun;76(6):438–441. doi: 10.1111/1523-1747.ep12521036. [DOI] [PubMed] [Google Scholar]
- Villars V., Jones T. C. Clinical efficacy and tolerability of terbinafine (Lamisil)--a new topical and systemic fungicidal drug for treatment of dermatomycoses. Clin Exp Dermatol. 1989 Mar;14(2):124–127. doi: 10.1111/j.1365-2230.1989.tb00908.x. [DOI] [PubMed] [Google Scholar]